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Statement of the Problem 
² In primary care, many patients will have mental health problems.  
Primary care providers might not prescribe certain antipsychotics, 
but they need to oversee the comprehensive health of the patients 
on these medications, including the patients’ mental health.  
However, due to a shortage of mental health professionals, many 
primary health care providers also need to supervise the 
antipsychotic medications.   
² If antipsychotic medications cause weight gain, it can result in 
non-compliance or increased risk of other comorbidities that 
medical health professionals will need to manage as the primary 
care providers. 
References 
² Antipsychotic medications are utilized for patients with many 
mental health problems including schizophrenia, attention deficit 
hyperactivity disorder, autism, bipolar mania, and psychotic 
depression.  The antipsychotic medications treat the symptoms 
associated with these mental health disorders.  
² Antipsychotic medications, while being efficacious to these 
symptoms, can have unwanted side effects, including weight gain.  
The purpose of this study was to determine if there is a strong 
relationship with antipsychotic medication use and weight gain.   
² The review of literature was conducted with an online search of 
Cochrane, PubMed, and PsycInfo for journal articles, research 
studies, and other scholarly reviews.  Articles included in the 
search described the proposed mechanisms of how antipsychotic 
medications can result in weight gain. 
² The literature review indicated antipsychotics contribute to 
increased weight gain with second generation antipsychotic 
medication use resulting in more weight gain than the use of first 
generation antipsychotic medications. 
² There are different types of antipsychotic medications including 
first and second generation antipsychotics.  The first generation 
antipsychotics have been prescribed for mental health problems 
since the 1950s.  The second generation antipsychotics, also 
known as atypical antipsychotics, are relatively newer 
medications with their development in the 1980s 
² According to the IMS Health Vector One National database, there 
were over 6.8 million antipsychotic medications prescribed in the 
United States in 2014.   
² This increase of individuals accessing mental health treatment, 
combined with the shortage of mental health professionals, means 
that primary care providers will likely take on the responsibility 
of managing a patient’s mental health medications. 
 
² In treating patients with mental health disorders, is there an 
association between the use of antipsychotic medications and weight 
gain? 
² In mental health patients prescribed antipsychotics, what are the 
proposed mechanisms of antipsychotic induced weight gain?   
² This scholarly project focused on the association between weight gain 
and the use of antipsychotic medications.  Additionally, the project 
used research to investigate mechanisms by which antipsychotic 
medication use can lead to weight gain. 
²  I would like to thank Dr. Nair, Bradley Curs, Dawn Hackman, Russell Kauffman, Kate 
Dietz, Kate McFarland, and Lisa Steers for all of your assistance.  I greatly appreciate 
your help and commitment to this scholarly project. 
² The increase of individuals accessing mental health treatment, 
combined with the shortage of mental health professionals, means 
that primary care providers will likely take on the responsibility of 
managing a patient’s mental health medications. 
² Due to this increased prescribing responsibility, primary care 
providers need to be aware of the antipsychotic medications and 
the side effects to provide effective mental and physical health 
plans.  There is a strong likelihood of non-compliance and 
discontinuation of antipsychotic medications due to the increase in 
weight gain.  
² Health care providers need to encourage a healthy diet and 
exercise for their patients, especially those on antipsychotic 
medications.  Regular exercise could help reduce with weight gain 
associated with the antipsychotic medication.   
² The weight of each patient should be monitored and recorded 
every visit.  This weight monitoring can show results of how well 
patients are adhering to their diet and exercise plans. 
² Outside contributing factors such as lack of access to 
transportation, inadequate healthy food choices, and financial 
limitations can affect the patients’ ability to adhere to their 
treatment plans.  The cost of healthy food choices can result in 
worse eating habits, adding to the weight gain side effects of 
antipsychotic medications.  Prescribing the appropriate generic 
medications can help reduce the financial burden of patients.   
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² Scigliano and Ronchetti (2013) found that antipsychotic 
medications were linked to an increase in insulin resistance.  Insulin 
resistance is a contributing factor to weight gain.  The authors 
proposed this mechanism works by increasing sympathetic tone 
with the blocking of dopamine D2 receptors.  Blocking the 
muscarinic M3 receptors inhibits parasympathetic activity as well.  
The combination of increased sympathetic tone and decreased 
parasympathetic activity on the pancreatic islets can increase 
insulin resistance 
² Tek, Ratliff, Reutenauer, Ganguli, and O’malley (2014) described 
on how antipsychotic induced weight gain is due to the blocking of 
dopamine D2 receptors.  These receptors are involved in the food 
reward system.  When the receptors are blocked, there can be an 
increase in overeating, resulting in weight gain. 
² Volpato, Zugno, and Quevedo (2013) proposed histamine H1 
receptors regulate appetite. Antipsychotic medications block 
histamine H1 receptors, leading to increased food consumption and 
weight gain. 
² Arrango et al. (2009) conducted a clinical trial, which compared two 
second generation antipsychotic medications, olanzapine and 
quetiapine, for their side effects and efficacy over a 180-day period.  
The olanzapine group gained more weight at 15.5 kg (p < 0.001), 
than the quetiapine group at 5.4 kg  (p = 0.004). 
² Martinez-Ortega et al. (2013) demonstrated that the second 
generation antipsychotics were associated with more weight gain 
then the first generation antipsychotics.  One of the studies 
analyzed showed a significantly higher (p < 0.05) mean weight 
gain for olanzapine compared to risperidone and haloperidol. 
